Mini Review
Accepted on 27 Dec 2023
NEW BETTER VERSION: The major epidemiologic, microbiologic, immunologic, and clinical aspects of Lyme disease that form the basis for a newly developed vaccine that may become available soon for human use
in Vaccines and Molecular Therapeutics












